Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Reply to Ward et al.
Vaidya JS, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, Williams NR, Brew-Graves C, Bernstein M, Holmes D, Vinante L, Pigorsch S, Lundgren S, Uhl V, Joseph D, Tobias JS. Vaidya JS, et al. Among authors: sperk e. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):256-259. doi: 10.1016/j.ijrobp.2022.10.009. Int J Radiat Oncol Biol Phys. 2023. PMID: 36526392 No abstract available.
A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy.
Aldraimli M, Soria D, Grishchuck D, Ingram S, Lyon R, Mistry A, Oliveira J, Samuel R, Shelley LEA, Osman S, Dwek MV, Azria D, Chang-Claude J, Gutiérrez-Enríquez S, De Santis MC, Rosenstein BS, De Ruysscher D, Sperk E, Symonds RP, Stobart H, Vega A, Veldeman L, Webb A, Talbot CJ, West CM, Rattay T; REQUITE consortium; Chaussalet TJ. Aldraimli M, et al. Among authors: sperk e. Comput Biol Med. 2021 Aug;135:104624. doi: 10.1016/j.compbiomed.2021.104624. Epub 2021 Jul 5. Comput Biol Med. 2021. PMID: 34247131
Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.
Krengli M, Calvo FA, Sedlmayer F, Sole CV, Fastner G, Alessandro M, Maluta S, Corvò R, Sperk E, Litoborski M, Pisani C, Fillini C, Fusconi F, Osti MF, Tomio L, Marsiglia H, Ciabattoni A, Polkowski W, Di Grazia A, Gava A, Kuten A, Iotti C, Gonzalez C, Sallabanda M, Dubois JB, Catalano G, Valentini V. Krengli M, et al. Among authors: sperk e. Strahlenther Onkol. 2013 Sep;189(9):729-37. doi: 10.1007/s00066-013-0395-1. Epub 2013 Jul 12. Strahlenther Onkol. 2013. PMID: 23842635
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.
Xu Q, Streuer A, Jann JC, Altrock E, Schmitt N, Flach J, Sens-Albert C, Rapp F, Wolf J, Nowak V, Weimer N, Obländer J, Palme I, Kuzina M, Jawhar A, Darwich A, Weis CA, Marx A, Wuchter P, Costina V, Jäger E, Sperk E, Neumaier M, Fabarius A, Metzgeroth G, Nolte F, Steiner L, Levkin PA, Jawhar M, Hofmann WK, Riabov V, Nowak D. Xu Q, et al. Among authors: sperk e. Nat Commun. 2023 Mar 17;14(1):1497. doi: 10.1038/s41467-023-37175-8. Nat Commun. 2023. PMID: 36932114 Free PMC article.
Correction to: Innovative radiation oncology Together-Precise, Personalized, Human.
Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M. Krug D, et al. Among authors: sperk e. Strahlenther Onkol. 2021 Dec;197(12):1049-1050. doi: 10.1007/s00066-021-01869-z. Strahlenther Onkol. 2021. PMID: 34731288 Free PMC article. No abstract available.
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, Giraldo A, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Lambrecht M, Lang P, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Valladares B, Talbot CJ, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, Lievens Y; REQUITE consortium. van der Weijst L, et al. Among authors: sperk e. Radiother Oncol. 2022 Nov;176:127-137. doi: 10.1016/j.radonc.2022.09.020. Epub 2022 Oct 3. Radiother Oncol. 2022. PMID: 36195214 Free PMC article.
Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, Suetterlin M, Wenz F. Welzel G, et al. Among authors: sperk e. Radiat Oncol. 2013 Jan 7;8:9. doi: 10.1186/1748-717X-8-9. Radiat Oncol. 2013. PMID: 23294485 Free PMC article. Clinical Trial.
74 results